Anastasiou Jiannis, Williams Roger
Second Department of Gastroenterology, Evangelismos Hospital, Athens, Greece (Jiannis Anastasiou).
Institute of Hepatology, Foundation for Liver Research, London (Roger Williams).
Ann Gastroenterol. 2013;26(2):128-131.
Bacterial infections are very common in advanced cirrhosis and are a leading cause of death of these patients. Early and appropriate empirical antibiotic treatment of infection is essential in determining patient's outcome. A strategy of careful restriction of prophylactic antibiotics to the high-risk populations could contribute to the reduction of multidrug resistant bacteria. This article reviews and reports the current knowledge in the use of antibiotics in the cirrhotic patient.
细菌感染在晚期肝硬化中非常常见，是这些患者死亡的主要原因。对感染进行早期且恰当的经验性抗生素治疗对于决定患者的预后至关重要。对高危人群谨慎限制预防性抗生素的使用策略有助于减少多重耐药菌。本文综述并报告了目前关于肝硬化患者使用抗生素的知识。
